Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.advancedenzymes.com | |
Market Cap | 4,461.22 Cr. | |
Enterprise Value(EV) | 4,355.89 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 12.26 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 32.54 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 42.26 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 115.43 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 3.46 | Calculated using Price: 398.95 |
Dividend Yield | 1.25 | Period Ending 2023-03 |
No. of Shares Subscribed | 11.18 Cr. | 111,824,075 Shares |
FaceValue | 2 | |
About Advanced Enzyme Technologies Ltd. | ||
The company is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (R&D) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions. Its experienced and qualified R&D team strives to develop creative, cost-effective unique and innovative solutions, thereby enabling their customers to develop superior products and processes. The company products assist its customers in making most of their resources, optimizing their processes, improving their product quality, saving their time and money while also mitigating the impact on the environment. It supplies these value-added and eco-safe enzyme products to diverse end-user industries like human healthcare and nutrition, animal nutrition, food processing, baking, dairy and cheese processing, fruit and vegetable processing, cereal extraction, brewing, grain processing, protein processing, oil and fat processing, biomass processing, textile processing, leather processing, paper & pulp processing, bio-fuels, bio-catalysis etc. Although, the company has the capability to manufacture enzymes using all the four natural origins viz. plant, animal, bacterial and fungal, their major focus is on developing enzymes through microbial fermentation. |
1 Day |
|
+1.22% |
1 Week |
|
+1.90% |
1 Month |
|
+9.45% |
3 Month |
|
+3.03% |
6 Month |
|
+29.38% |
1 Year |
|
+45.13% |
2 Year |
|
+35.21% |
5 Year |
|
+109.15% |
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 27.31 | 31.32 | 25.06 | 18.34 | 18.82 | 17.61 | 16.77 | 12.04 | 8.94 | |
Return on Capital Employed (%) | 25.49 | 35.68 | 31.53 | 25.88 | 24.96 | 23.21 | 22.93 | 16.66 | 12.26 | |
Return on Assets (%) | 12.81 | 17.81 | 18 | 14.28 | 15.13 | 14.98 | 14.27 | 10.28 | 7.78 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 212 | 278 | 464 | 559 | 679 | 840 | 971 | 1,089 | 1,235 | 1,248 | |
Non Curr. Liab. | 64 | 56 | 32 | 43 | 30 | 39 | 49 | 59 | 49 | 46 | |
Curr. Liab. | 131 | 111 | 62 | 99 | 65 | 60 | 68 | 60 | 78 | 87 | |
Minority Int. | 4 | 5 | 21 | 23 | 26 | 28 | 62 | 52 | 49 | 50 | |
Equity & Liab. | 412 | 450 | 583 | 727 | 805 | 971 | 1,149 | 1,260 | 1,411 | 1,433 | |
Non Curr. Assets | 307 | 311 | 440 | 512 | 518 | 591 | 633 | 656 | 688 | 696 | |
Curr. Assets | 104 | 140 | 138 | 211 | 282 | 376 | 516 | 604 | 722 | 737 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 412 | 450 | 583 | 727 | 805 | 971 | 1,149 | 1,260 | 1,411 | 1,433 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 223 | 294 | 329 | 391 | 420 | 444 | 502 | 529 | 541 | 605 | |
Other Income | 3 | 1 | 3 | 3 | 6 | 6 | 9 | 6 | 25 | 38 | |
Total Income | 226 | 295 | 332 | 394 | 425 | 450 | 511 | 536 | 566 | 643 | |
Total Expenditure | -133 | -156 | -178 | -227 | -237 | -241 | -269 | -327 | -383 | -412 | |
PBIDT | 93 | 139 | 154 | 166 | 188 | 209 | 241 | 209 | 183 | 231 | |
Interest | -9 | -8 | -4 | -9 | -5 | -4 | -3 | -3 | -3 | -3 | |
Depreciation | -9 | -9 | -13 | -18 | -21 | -26 | -29 | -35 | -35 | -34 | |
Taxation | -23 | -41 | -44 | -45 | -46 | -46 | -59 | -47 | -37 | -51 | |
Exceptional Items | -4 | -4 | -4 | ||||||||
PAT | 52 | 77 | 93 | 94 | 116 | 133 | 151 | 124 | 104 | 139 | |
Minority Interest | -1 | -1 | -1 | -3 | -5 | -4 | -5 | -4 | 2 | -2 | |
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 51 | 76 | 92 | 90 | 111 | 129 | 146 | 120 | 106 | 137 | |
Adjusted EPS | 5 | 7 | 8 | 8 | 10 | 12 | 13 | 11 | 9 | 12 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 56 | 54 | 93 | 107 | 116 | 129 | 141 | 163 | 122 | 140 | |
Cash Fr. Inv. | -9 | -11 | -5 | -60 | -78 | -125 | -45 | -26 | -4 | -298 | |
Cash Fr. Finan. | -33 | -36 | -63 | -65 | -2 | -43 | -39 | -26 | -49 | -26 | |
Net Change | 13 | 6 | 26 | -18 | 36 | -39 | 58 | 111 | 70 | -184 | |
Cash & Cash Eqvt | 2 | 4 | 25 | 8 | 61 | 23 | 83 | 192 | 267 | 96 |
Sat, 04 May 2024
Intimation Of Board Meeting Record Date For Interim Dividend If Declared By The Board And Closure Of Trading Window This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday May 11 2024 inter-alia to consider the following:(i) to consider & approve annual financial statements (Standalone and consolidated) of the Company for financial year ended March 31 2024 along with results of the fourth quarter;(ii) to consider & recommend Final Dividend if any for the financial year ended March 31 2024 and/or consider and declare Interim Dividend if any for the financial year ended March 31 2025.Record date for determining the shareholders for the payment of the aforesaid Interim Dividend for FY 2024-25 if any declared by the Board of Directors of the Company shall be Saturday May 18 2024 |
Sat, 04 May 2024
Intimation Of Record Date For Interim Dividend If Any Declared By The Board This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday May 11 2024 inter-alia to consider & recommend Final Dividend if any for the financial year ended March 31 2024 and/or to consider & declare Interim Dividend if any for the financial year ended March 31 2025.The Record date for determining the shareholders for the payment of the aforesaid Interim Dividend for FY 2024-25 if any declared by the Board of Directors of the Company shall be Saturday May 18 2024 |
Sat, 04 May 2024
Board Meeting Intimation for Intimation Of Board Meeting Record Date For Interim Dividend If Declared By The Board And Closure Of Trading Window Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2024 inter alia to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held onSaturday May 11 2024 inter alia to consider the following:To consider & approve annual Financial Statements (Standalone & Consolidated) of the Company forthe financial year ended March 31 2024 along with results of the fourth quarter;To consider & recommend Final dividend if any for the financial year ended March 31 2024 and/or to consider & declare Interim Dividend if any for the financial year ended March 31 2025.The Record date for determining the shareholders for the payment of the aforesaid Interim Dividend for FY2024-25 if any declared by the Board of Directors of the Company shall be Saturday May 18 2024.Closure of Trading Window:Further to our letter dated March 29 2024 intimating closure of Trading Window we wish to inform you that the Trading Window for dealing in the Securities of the Company will continue to remain closed up to May 13 2024 |
Mon, 06 May 2024 |
Closing Above Previous High |
Close Within 52 Week High Zone |
Making Higher Highs for 2 Days |
High Increase in 1 Month |
High Increase in 6 Months |